Advertisement
Demo

Roche's lung cancer combo treatment wins FDA approval

Dec 07, 2018 , Reuters
Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a form of lung cancer.


Read the full story...


Trending healthcare news keywords at this moment

obamacare china healthcare blood drug court planned parenthood case hospitals risk breast cancer study doctors women holidays tied autism heart flu life stop state gun deaths kids care california mental holiday safety hospital patients weight higher beef digital fda opioid system patient diabetes data congress people amp disease food surgery unveils launches report brings recalled tip pain linked research medicaid finds brain